{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T05:02:16Z","timestamp":1780030936922,"version":"3.53.1"},"reference-count":63,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Sciences"],"abstract":"<jats:p>Background: Heart failure (HF) has traditionally been interpreted through hemodynamic, neurohormonal, and cardiorenal frameworks. Although these models explain many aspects of clinical decompensation, they do not fully account for persistent tissue congestion, unresolved myocardial edema, chronic sterile inflammation, and progressive fibrosis despite optimized therapy. Objectives: To review the anatomy, physiology, and pathobiological relevance of the cardiac lymphatic system in HF and to evaluate whether cardiac lymphatic dysfunction constitutes a mechanistic bridge linking congestion, inflammation, and adverse remodeling. Methods: This narrative review was based on a structured literature search of PubMed\/MEDLINE, supplemented by manual backward reference screening and bibliographic verification through journal webpages. The search covered January 2000 to 15 April 2026, with emphasis on 2018 onward and on seminal mechanistic studies. Search domains included cardiac lymphatics, heart failure, lymphangiogenesis, myocardial edema, congestion, inflammation, myocardial infarction, pressure overload, and HFpEF. Results: Cardiac lymphatics regulate myocardial clearance of interstitial fluid, proteins, cytokines, lipids, and immune cells. Preclinical experimental evidence, mainly derived from myocardial infarction, pressure-overload, and lymphatic-insufficiency models, indicates that impaired lymphatic transport or insufficient lymphangiogenic adaptation promotes myocardial edema, inflammatory persistence, fibroblast activation, collagen deposition, and ventricular dysfunction. Human observational and early translational studies suggest that lymphatic dysregulation may also be relevant in selected HF phenotypes, although direct clinical evidence remains limited. Conversely, lymphangiogenic and lymphatic-restorative strategies, especially through the VEGF-C\/VEGFR-3 axis, reduce edema, enhance inflammatory resolution, attenuate fibrosis, and improve ventricular performance in preclinical models. Conclusions: Cardiac lymphatic dysfunction provides a compelling conceptual framework that links congestion and inflammation in HF. Rather than acting as a passive bystander, the cardiac lymphatic circulation appears to be an active determinant of myocardial homeostasis and disease progression. Recognition of lymphatic insufficiency as a pathogenic component of HF may open new diagnostic and therapeutic avenues, including tissue-focused decongestion, lymphatic phenotyping, and targeted lymphatic repair.<\/jats:p>","DOI":"10.3390\/medsci14020266","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T14:12:54Z","timestamp":1779286374000},"page":"266","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cardiac Lymphatic Dysfunction in Heart Failure: A New Paradigm for Congestion, Inflammation, and Therapy"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5547-4025","authenticated-orcid":false,"given":"Francisco","family":"Epelde","sequence":"first","affiliation":[{"name":"Internal Medicine Department, Parc Taul\u00ed Hospital Universitari, Institut d\u2019Investigaci\u00f3 i Innovaci\u00f3 Parc Taul\u00ed (I3PT-CERCA), Universitat Aut\u00f2noma de Barcelona, 08208 Sabadell, Spain"},{"name":"APTIMA Centre Clinic, Mutua de Terrassa, 08221 Terrassa, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchf.2012.10.002","article-title":"Heart failure","volume":"1","author":"Braunwald","year":"2013","journal-title":"JACC Heart Fail."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/s41569-020-0379-7","article-title":"Congestion in heart failure: A contemporary look at physiology, diagnosis and treatment","volume":"17","author":"Boorsma","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/ejhf.1369","article-title":"The use of diuretics in heart failure with congestion: A position statement from the Heart Failure Association of the European Society of Cardiology","volume":"21","author":"Mullens","year":"2019","journal-title":"Eur. J. Heart Fail."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1161\/CIRCULATIONAHA.108.783910","article-title":"Transition from chronic compensated to acute decompensated heart failure: Pathophysiological insights obtained from continuous monitoring of intracardiac pressures","volume":"118","author":"Zile","year":"2008","journal-title":"Circulation"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrcardio.2014.28","article-title":"The inflammatory response in myocardial injury, repair, and remodelling","volume":"11","author":"Frangogiannis","year":"2014","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/s41577-018-0065-8","article-title":"Cardioimmunology: The immune system in cardiac homeostasis and disease","volume":"18","author":"Swirski","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.15420\/cfr.2019.18","article-title":"Congestion and Diuretic Resistance in Acute or Worsening Heart Failure","volume":"6","author":"Thorvaldsen","year":"2020","journal-title":"Card. Fail Rev."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1161\/CIRCRESAHA.116.302317","article-title":"Innate immunity and the failing heart: The cytokine hypothesis revisited","volume":"116","author":"Mann","year":"2015","journal-title":"Circ. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1161\/CIRCRESAHA.116.303577","article-title":"The biological basis for cardiac repair after myocardial infarction: From inflammation to fibrosis","volume":"119","author":"Prabhu","year":"2016","journal-title":"Circ. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/cvr\/cvaa324","article-title":"Cardiac fibrosis","volume":"117","author":"Frangogiannis","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1089\/15396850360495655","article-title":"The lymphatic system in body homeostasis: Physiological conditions","volume":"1","author":"Olszewski","year":"2003","journal-title":"Lymphat. Res. Biol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1146\/annurev-fluid-122316-045259","article-title":"Lymphatic system flows","volume":"50","author":"Moore","year":"2018","journal-title":"Annu. Rev. Fluid Mech."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1146\/annurev-immunol-041015-055354","article-title":"The lymphatic system: Integral roles in immunity","volume":"35","author":"Randolph","year":"2017","journal-title":"Annu. Rev. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.cell.2020.06.039","article-title":"The lymphatic vasculature in the 21st century: Novel functional roles in homeostasis and disease","volume":"182","author":"Oliver","year":"2020","journal-title":"Cell"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1152\/physrev.00037.2011","article-title":"Interstitial fluid and lymph formation and transport: Physiological regulation and roles in inflammation and cancer","volume":"92","author":"Wiig","year":"2012","journal-title":"Physiol. Rev."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1136\/heartjnl-2018-314461","article-title":"Role of the lymphatic vasculature in cardiovascular medicine","volume":"105","author":"Telinius","year":"2019","journal-title":"Heart"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.jacc.2020.05.076","article-title":"Role of cardiac lymphatics in myocardial edema and fibrosis","volume":"76","author":"Brakenhielm","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jacc.2021.04.090","article-title":"Lymphatic dysregulation in patients with heart failure","volume":"78","author":"Fudim","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jacc.2021.05.021","article-title":"Pathophysiology of the lymphatic system in patients with heart failure","volume":"78","author":"Itkin","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_22","first-page":"1436","article-title":"Myocardial oedema: Pathophysiological basis and role in diagnosis and risk stratification","volume":"9","author":"Laundos","year":"2022","journal-title":"ESC. Heart Fail."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"23509","DOI":"10.1038\/s41598-024-74099-9","article-title":"Characterizing myocardial edema and fibrosis in hypertensive crisis with cardiovascular magnetic resonance imaging","volume":"14","author":"Talle","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Ravaud, C., Bonzanni, N., and Lund, A.W. (2021). Lymphatic clearance of immune cells in cardiovascular disease. Cells, 10.","DOI":"10.3390\/cells10102594"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1161\/CIRCULATIONAHA.115.020143","article-title":"Selective stimulation of cardiac lymphangiogenesis reduces myocardial edema and fibrosis leading to improved cardiac function following myocardial infarction","volume":"133","author":"Henri","year":"2016","journal-title":"Circulation"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1172\/JCI97192","article-title":"The cardiac lymphatic system stimulates resolution of inflammation following myocardial infarction","volume":"128","author":"Vieira","year":"2018","journal-title":"J. Clin. Investig."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1161\/ATVBAHA.120.314370","article-title":"Lymphatic and immune cell cross-talk regulates cardiac recovery after experimental myocardial infarction","volume":"40","author":"Houssari","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1161\/CIRCRESAHA.118.313835","article-title":"Adrenomedullin induces cardiac lymphangiogenesis after myocardial infarction and regulates cardiac edema via connexin 43","volume":"124","author":"Trincot","year":"2019","journal-title":"Circ. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/cvr\/cvac086","article-title":"Regulation and impact of cardiac lymphangiogenesis in pressure-overload-induced heart failure","volume":"119","author":"Heron","year":"2023","journal-title":"Cardiovasc. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e374","DOI":"10.1002\/ctm2.374","article-title":"VEGF-C\/VEGFR-3 axis protects against pressure-overload-induced cardiac dysfunction through regulation of lymphangiogenesis","volume":"11","author":"Lin","year":"2021","journal-title":"Clin. Transl. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.jacbts.2023.01.008","article-title":"Cardiac lymphatic insufficiency leads to diastolic dysfunction via myocardial morphologic change","volume":"8","author":"Pu","year":"2023","journal-title":"JACC Basic Transl. Sci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1161\/CIRCRESAHA.125.325516","article-title":"Gut-Heart Axis: The Role of Gut Microbiota and Metabolites in Heart Failure","volume":"136","author":"Snelson","year":"2025","journal-title":"Circ. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"4","DOI":"10.14797\/mdcvj.1121","article-title":"The Kidney in Heart Failure: The Role of Venous Congestion","volume":"18","author":"Ibrahim","year":"2022","journal-title":"Methodist Debakey Cardiovasc. J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.jacbts.2021.10.003","article-title":"Targeting the lymphatic system for interstitial decongestion","volume":"6","author":"Martens","year":"2021","journal-title":"JACC Basic Transl. Sci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1016\/j.jacc.2020.10.022","article-title":"Reduced Lymphatic Reserve in Heart Failure With Preserved Ejection Fraction","volume":"76","author":"Rossitto","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1161\/CIRCRESAHA.115.306544","article-title":"Lymphatic system in cardiovascular medicine","volume":"118","author":"Aspelund","year":"2016","journal-title":"Circ. Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1089\/lrb.2008.1010","article-title":"Morphological and quantitative changes of the initial myocardial lymphatics in terminal heart failure","volume":"7","author":"Dashkevich","year":"2009","journal-title":"Lymphat. Res. Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nature14483","article-title":"Cardiac lymphatics are heterogeneous in origin and respond to injury","volume":"522","author":"Klotz","year":"2015","journal-title":"Nature"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/s41569-020-00489-x","article-title":"The evolving cardiac lymphatic vasculature in development, repair and regeneration","volume":"18","author":"Klaourakis","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41569-018-0087-8","article-title":"Cardiac lymphatics in health and disease","volume":"16","author":"Brakenhielm","year":"2019","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1093\/cvr\/cvq062","article-title":"Microvascular fluid exchange and the revised Starling principle","volume":"87","author":"Levick","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1084\/jem.20171868","article-title":"Organ-specific lymphatic vasculature: From development to pathophysiology","volume":"215","author":"Petrova","year":"2018","journal-title":"J. Exp. Med."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Kiseleva, D.G., Kirichenko, T.V., Markina, Y.V., Cherednichenko, V.R., Gugueva, E.A., and Markin, A.M. (2024). Mechanisms of Myocardial Edema Development in CVD Pathophysiology. Biomedicines, 12.","DOI":"10.3390\/biomedicines12020465"},{"key":"ref_44","first-page":"253","article-title":"Effect of cardiac lymph flow obstruction on cardiac collagen synthesis and interstitial fibrosis in rabbits","volume":"101","author":"Kong","year":"2006","journal-title":"Basic Res. Cardiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1161\/CIRCULATIONAHA.109.916346","article-title":"Monocytes: Protagonists of infarct inflammation and repair after myocardial infarction","volume":"121","author":"Nahrendorf","year":"2010","journal-title":"Circulation"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1365-2559.2007.02785.x","article-title":"Lymphangiogenesis in myocardial remodelling after infarction","volume":"51","author":"Ishikawa","year":"2007","journal-title":"Histopathology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1093\/cvr\/cvaa291","article-title":"The physiological and pathological functions of VEGFR3 in cardiac and lymphatic development and related diseases","volume":"117","author":"Monaghan","year":"2021","journal-title":"Cardiovasc Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/path.6093","article-title":"Mechanisms regulating vascular and lymphatic regeneration in the heart after myocardial infarction","volume":"260","author":"Berkeley","year":"2023","journal-title":"J. Pathol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e140685","DOI":"10.1172\/JCI140685","article-title":"Macrophage-produced VEGFC is induced by efferocytosis to ameliorate cardiac injury and inflammation","volume":"132","author":"Glinton","year":"2022","journal-title":"J. Clin. Investig."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e147070","DOI":"10.1172\/JCI147070","article-title":"Genetic blockade of lymphangiogenesis does not impair cardiac function after myocardial infarction","volume":"131","author":"Keller","year":"2021","journal-title":"J. Clin. Investig."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"16801","DOI":"10.1038\/s41598-021-95723-y","article-title":"Cardiac macrophage subsets differentially regulate lymphatic network remodeling during pressure overload","volume":"11","author":"Bizou","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A novel paradigm for heart failure with preserved ejection fraction","volume":"62","author":"Paulus","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00395-020-0798-y","article-title":"Microvascular and lymphatic dysfunction in HFpEF and its associated comorbidities","volume":"115","author":"Cuijpers","year":"2020","journal-title":"Basic Res. Cardiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e015761","DOI":"10.1161\/JAHA.119.015761","article-title":"Distinct characteristics of VEGF-D and VEGF-C to predict mortality in patients with suspected or known coronary artery disease","volume":"9","author":"Wada","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e58376","DOI":"10.7554\/eLife.58376","article-title":"Lymphangiogenic therapy prevents cardiac dysfunction by ameliorating inflammation and hypertension","volume":"9","author":"Song","year":"2020","journal-title":"eLife"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e153448","DOI":"10.1172\/JCI153448","article-title":"Lymphatics in the broken heart","volume":"131","author":"Chen","year":"2021","journal-title":"J. Clin. Investig."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1007\/s10741-021-10188-5","article-title":"The role of lymphangiogenesis in cardiovascular diseases","volume":"27","author":"Ji","year":"2022","journal-title":"Heart Fail. Rev."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Shimizu, Y., Luo, H., and Murohara, T. (2024). Disease-specific alteration of cardiac lymphatics: A review from animal disease models to clinics. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms251910656"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41392-023-01723-x","article-title":"Lymphatic vessel: Origin, heterogeneity, biological functions and therapeutic targets","volume":"9","author":"Hu","year":"2024","journal-title":"Signal Transduct. Target Ther."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/ATVBAHA.122.318406","article-title":"Promoting lymphangiogenesis and lymphatic growth and remodeling to treat cardiovascular and metabolic diseases","volume":"43","author":"Liu","year":"2023","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1002\/ehf2.15192","article-title":"Design and rationale of the eLym system for decompensation of excess lymphatic fluid via the thoracic duct in acute heart failure (DELTA-HF)","volume":"12","author":"Biegus","year":"2025","journal-title":"ESC. Heart Fail."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s12265-025-10592-4","article-title":"Lymphatic drainage in patients with heart failure: A feasibility study","volume":"18","author":"Salah","year":"2025","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"ref_63","first-page":"23S","article-title":"Device therapy nello scompenso cardiaco cronico: Un caso di cardiomiopatia ipertrofica trattato con terapia di modulazione della contrattilit\u00e0 cardiaca","volume":"23","author":"Gragnano","year":"2022","journal-title":"G. Ital. Cardiol."}],"container-title":["Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3271\/14\/2\/266\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T04:11:49Z","timestamp":1780027909000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3271\/14\/2\/266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":63,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["medsci14020266"],"URL":"https:\/\/doi.org\/10.3390\/medsci14020266","relation":{},"ISSN":["2076-3271"],"issn-type":[{"value":"2076-3271","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]}}}